Top 8 out of 43) Zong H, Gozman A, Caldas-Lopes E, Taldone T, Sturgill E, Brennan S, Ochiana SO, Claire EM, Sen S, Rodina A, Koren J 3rd, Becker MW, Rudin CM, Melnick A, Levine RL, Roboz GJ, Nimer SD, Chiosis G, Guzman ML. A Hyperactive Signalosome in Acute Myeloid Leukemia Drives Addiction to a Tumor-Specific Hsp90 Species. Cell Rep. 2015 Dec 15;13(10):2159-73. PMID 26628369 Ma Q, Gomes EM, Lo AS, Junghans RP. Advanced generation anti-prostate specific membrane antigen designer T Cells for prostate cancer immunotherapy. Prostate. 2014 Feb;74(3):286-96.PMID:24174378 Jessica. Gomes DaGama, Kamalika Moulick, James H. Ahn, Hongliang Zong, Anna Rodina, Leandro Cerchietti, Eloisi Caldas-Lopes, Kristin Beebe, Fabiana Perna, Katerina Hatzi, Ly P. Vu, Xinyang Zhao, Danuta Zatorska, Tony Taldone, Peter Smith-Jones, Mary Alpaugh, Steven S. Gross, Nagavarakishore Pillarsetty, Thomas Ku, Jason S. Lewis, Steven M. Larson, Ross Levine, Hediye Erdjument-Bromage, Monica L. Guzman, Stephen D. Nimer, Ari Melnick, Len Neckers, Gabriela Chiosis Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. AACR, 2012, Chicago, IL Taldone T, Claire EM, Zong H, Sen S, Alpaugh ML, Zatorska D, Alonso-Sabadell R, Guzman ML, Chiosis G. Synthesis of purine-scaffold fluorescent probes for heat shock protein 90 with use in flow cytometry and fluorescence microscopy. Bioorg Med Chem Lett. 2011 Sep 15;21(18):5347-52. Epub 2011 Jul 14. PMID: 21802945 Gomes EM, Rodrigues MS, Phadke AP, Butcher LD, Starling C, Chen S, Chang D, Hernandez-Alcoceba R, Newman JT, Stone MJ, Tong AW. Anti-tumor Activity of an Oncolytic Adenoviral-CD40 ligand (CD154) Transgene Construct in Human Breast Cancer Cells. Clin Cancer Res. 2009; Feb 15; 15(4): 1317-1325. PMID:19228733 Gomes EM, Ma Q, Junghans RP. Anti-CEA Third Generation Immunologlobulin Chimeric T Cell Receptor Molecules for Adoptive Cancer Immunotherapy. AACR Meeting , Apr 2008, Abstract No. 4625 Gomes EM, Rodrigues MS, Alcoceba Hernandez R, Kansopon J, Newman J, Stone M.J, Tong AW. Enhanced anti-tumor growth inhibition by a conditional-replicative adenovirus armed with the CD154 (CD40L) transgene in human breast cancer cells. AACR Meeting Abstracts, Apr 2006; 2006: 512 Gomes EM, Rodrigues MS, Alcoceba Hernandez R, Kansopon J, Newman J, Stone MJ. Tong A.W. Conditional-replicative adenovirus armed with the CD154 (CD40L) displayed enhanced anti-tumor growth inhibitory properties against human breast cancer cells. Proc.13thAnnual Conference on the Gene Therapy of Cancer, San Diego, CA. 2005. (Abstract invited for oral presentation)